S

trong data science is critical to getting a better understanding of clinical trial results — and perhaps no one understands that better than the Food and Drug Administration.

So the agency’s Oncology Center for Excellence has harnessed computer modeling tools to help make better sense of clinical data — so as to help guide companies into developing better clinical trials. It’s a collaborative effort, with FDA working with academia and other government agencies to help make sense of the jumbles of data that are presented to FDA.

Unlock this article by subscribing to STAT Plus today. Try it FREE for 30 days and cancel anytime!

SUBSCRIBE TODAY

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.

Privacy Policy